Aminoglycosides are broad spectrum antibiotics that act by binding to 16S rRNA of bacteria. The wide spread of aminoglycoside resistance threatens the use of these important medicines. Two general approaches can be used to address the aminoglycoside resistance problem. One…

In-silico methods used to aid the development of therapeutic drugs have gained utility in the recent past and continue to grow in importance. Small molecule drugs for the use in the treatment of type 2 diabetes were designed using computational…

Aminoglycosides are broad-spectrum antibiotics that target the A-site of bacterial 16S ribosomal RNA. Their use, however, is increasingly threatened by the rapid spread of resistance. One of the most common determinants of aminoglycoside resistance in bacteria is the expression of…